Advances in Virology / 2013 / Article / Tab 1

Research Article

Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver

Table 1

Patient characteristics, clinical profiles, and immunological outcomes.

Antibody titers
226.88 ± 164
IU/mL
TotalNonresponders
<10 IU/mL
Partial
responders
10–100 IU/mL
Responders
>100 IU/mL
value

Age group 47.48 9.37 [years]
 <50 303 [10%]6 [20%]21 [70%]0.03
 >50 228 [36%]5 [23%]9 [41%]
 Total 5211 [21%]11 [21%]30 [58%]
Gender
 Female152 [13%]2 [13%]11 [74%]0.43
 Male379 [24%]8 [22%]20 [54%]
 Total 5211 [21%]10 [19%]31 [60%]
Etiology
 Alcohol278 [30%]7 [26%]12 [44%]0.36
 Hepatitis C81 [12%]1 [12%]6 [76%]
 Cryptogenic132 [15%]2 [15%]9 [70%]
 Others4004 [100%]
 Total5211 [21%]10 [19%]31 [60%]
Child’s class
 A 252 [8%]1 [4%]22 [88%]<0.0001
 B279 [33.3%]9 [33.3%]9 [33.3%]
 Total5211 [21%]10 [19%]31 [60%]

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.